• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Disintegrin and metalloproteinase domain-containing protein 7 (ADAM7), Truncated

ACP12113

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP12113 Target NameADAM7
Target SynonymsADAM7; GP83Disintegrin and metalloproteinase domain-containing protein 7; ADAM 7; Sperm maturation-related glycoprotein GP-83FormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Protein LengthPartial
Purity>85% (SDS-PAGE)Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ9H2U9
Background Information
  • Uniprot Id

    Q9H2U9

  • Target Species

    Human

  • Target Name

    ADAM7

  • Target Full Name

    Disintegrin and metalloproteinase domain-containing protein 7

  • Target Function

    May play an important role in male reproduction including sperm maturation and gonadotrope function. This is a non catalytic metalloprotease-like protein.

  • Target Involvement

    Has been found to be frequently mutated in melanoma. ADAM7 mutations may play a role in melanoma progression and metastasis.

  • Target Subcellular Location

    Membrane; Single-pass type I membrane protein.

  • Target Tissue Specificity

    Not detected in healthy melanocytes. Expressed in melanoma cells.

  • Target Synonyms

    ADAM7; GP83Disintegrin and metalloproteinase domain-containing protein 7; ADAM 7; Sperm maturation-related glycoprotein GP-83

Inquire Recombinant Human Disintegrin and metalloproteinase domain-containing protein 7 (ADAM7), Truncated Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification